Prognostic significance of immune landscape in tumour microenvironment of endometrial cancer

J Cell Mol Med. 2020 Jul;24(14):7767-7777. doi: 10.1111/jcmm.15408. Epub 2020 May 19.

Abstract

Tumour microenvironment (TME) is crucial to tumorigenesis. This study aimed to uncover the differences in immune phenotypes of TME in endometrial cancer (EC) using Uterine Corpus Endometrial Carcinoma (UCEC) cohort and explore the prognostic significance. We employed GVSA enrichment analysis to cluster The Cancer Genome Atlas (TCGA) EC samples into immune signature cluster modelling, evaluated immune cell profiling in UCEC cohort (n = 538) and defined four immune subtypes of EC. Next, we analysed the correlation between immune subtypes and clinical data including patient prognosis. Furthermore, we analysed the expression of immunomodulators and DNA methylation modification. The profiles of immune infiltration in TCGA UCEC cohort showed significant difference among four immune subtypes of EC. Among each immune subtype, natural killer T cells (NKT), dendritic cells (DCs) and CD8+ T cells were significantly associated with EC patients survival. Each immune subtype exhibited specific molecular classification, immune cell characterization and immunomodulators expression. Moreover, the expression immunomodulators were significantly related to DNA methylation level. In conclusion, the identification of immune subtypes in EC tissues could reveal unique immune microenvironments in EC and predict the prognosis of EC patients.

Keywords: TCGA; endometrial cancer; immune infiltration; tumour microenvironment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor
  • Carcinogenesis / genetics
  • Carcinogenesis / immunology
  • Carcinogenesis / metabolism
  • DNA Methylation
  • Disease Susceptibility / immunology*
  • Endometrial Neoplasms / etiology*
  • Endometrial Neoplasms / mortality*
  • Endometrial Neoplasms / pathology
  • Female
  • Gene Expression Profiling
  • Humans
  • Immunity
  • Immunomodulation / genetics
  • Lymphocytes, Tumor-Infiltrating / immunology
  • Lymphocytes, Tumor-Infiltrating / metabolism
  • Prognosis
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / metabolism
  • T-Lymphocyte Subsets / pathology
  • Tumor Microenvironment / immunology*

Substances

  • Biomarkers, Tumor